2024 |
BeiGene Ltd - ADR
|
Independent Director |
502.4 K |
- |
2024 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
469.3 K |
-0.0 % |
2024 |
Legend Biotech Corp - ADR
|
Independent Director |
- |
- |
2023 |
BeiGene Ltd - ADR
|
Independent Director |
501.5 K |
1.2 % |
2023 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
469.4 K |
0.8 % |
2023 |
Molecular Templates Inc
|
Independent Director |
49.3 K |
-11.6 % |
2023 |
Legend Biotech Corp - ADR
|
Independent Director |
- |
- |
2022 |
BeiGene Ltd - ADR
|
Independent Director |
495.7 K |
0.8 % |
2022 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
465.8 K |
-40.0 % |
2022 |
Molecular Templates Inc
|
Independent Director |
55.7 K |
-63.8 % |
2022 |
Legend Biotech Corp - ADR
|
Independent Director |
- |
- |
2021 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
776.8 K |
- |
2021 |
BeiGene Ltd - ADR
|
Independent Director |
492.0 K |
83.1 % |
2021 |
Molecular Templates Inc
|
Independent Director |
154.0 K |
-33.9 % |
2021 |
Legend Biotech Corp - ADR
|
Independent Director |
- |
- |
2020 |
BeiGene Ltd - ADR
|
Independent Director |
268.7 K |
- |
2020 |
Molecular Templates Inc
|
Independent Director |
233.0 K |
-11.4 % |
2020 |
Legend Biotech Corp - ADR
|
Independent Director |
- |
- |
2019 |
Molecular Templates Inc
|
Independent Director |
263.1 K |
- |
2019 |
Legend Biotech Corp - ADR
|
Independent Director |
- |
- |